DS

Debra Schaumberg

Clinical Advisor at Mimetogen Pharmaceuticals

Dr. Schaumberg is an internationally recognized expert in ophthalmology clinical development, medical affairs, and epidemiology. She brings over 20 years of experience designing and leading early through late phase randomized trials and all aspects of real-world evidence generation and integration, including pivotal work in DED.

She brings diverse experience from academia, biotherapeutic start-ups, venture capital teams, and biopharma, and has authored hundreds of scientific publications, lectures, and scientific presentations. She is currently Vice President, Scientific Affairs at Evidera-PPD, with adjunct positions at the Harvard TH Chan School of Public Health and the University of Utah School of Medicine. Debra received her ScD from the Harvard TH Chan School of Public Health, an MPH from the Johns Hopkins Bloomberg School of Hygiene and Public Health, and an OD from the Illinois College of Optometry.